TABLE 4

Biodistribution of [111In]Z-070 in Double (Rat AR4-2J and Human PC-3) Tumor-Bearing Athymic Mice

OrganTime after injection
1 h4 h24 h
Blood0.78 ± 0.250.38 ± 0.270.40 ± 0.50
Liver0.95 ± 0.190.55 ± 0.070.28 ± 0.04
Heart0.84 ± 0.250.49 ± 0.120.30 ± 0.01
Kidneys9.37 ± 3.805.49 ± 1.990.78 ± 0.18
Stomach1.52 ± 0.240.68 ± 0.130.16 ± 0.08
Intestine6.41 ± 0.596.78 ± 1.491.30 ± 0.11
Spleen1.21 ± 0.381.07 ± 0.310.28 ± 0.04
Muscle0.56 ± 0.190.33 ± 0.030.33 ± 0.08
Lung1.23 ± 0.380.38 ± 0.040.48 ± 0.23
Pancreas43.04 ± 13.4425.36 ± 1.432.16 ± 0.68
AR4-2J tumor3.24 ± 0.722.72 ± 0.561.87 ± 0.37
PC-3 tumor4.67 ± 1.602.57 ± 0.561.19 ± 0.27
OrganBlocking at 4 h after injection*
100 μg250 μg
Stomach1.17 ± 0.561.37 ± 0.47
Intestine1.40 ± 0.211.53 ± 0.36
Pancreas1.44 ± 0.131.14 ± 0.13
AR4-2J tumor1.88 ± 0.591.22 ± 0.22
PC-3 tumor3.00 ± 1.261.85 ± 0.12
  • * Blocking by coinjection of 100 or 250 μg [Tyr4]BB.